Back to Journals » Lung Cancer: Targets and Therapy » Volume 9

Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation

Total article views   Abstract views HTML views PDF downloads Totals
1,201 Dovepress* 1,052 97+ 278 1,149
PubMed Central* 0 52 21 52
Totals 1,052 149 299 1,201
*Since 8 November 2018
+Since July 2016

View citations on PubMed Central and Google Scholar